Home Healthcare Medical Devices Infusion Pumps Market

Infusion Pumps Market Size, Share & Trends Analysis Report By Products (Insulin Infusion Pump, Large Volume Infusion Pump, Syringe Infusion Pump, Enteral Feeding Pump, Others), By Technology (Traditional Infusion Pumps, Specialty Infusion Pump), By Usage (Stationary Infusion Pump, Ambulatory Infusion Pump), By Applications (Diabetes, Oncology, Gastroenterology, Pediatric and Neonatology, Pain Management, Others), By End-Users (Hospital, Home Healthcare, Nursing Home, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Infusion Pumps Market Size

The global infusion pumps market size was valued at USD 16.65 billion in 2025 and is projected to grow from USD 18.07 billion in 2026 to USD 34.70 billion by 2034, registering a CAGR of 8.5% during the forecast period from 2026 to 2034. North America dominated the infusion pumps market with a market share of 39% in 2025.

Infusion pumps are medical devices that deliver controlled quantities of fluids, such as nutrients and medications, into a patient's body. Although arterial, subcutaneous, and epidural infusions are occasionally used, they are administered intravenously. Fluids can be given in methods that would be prohibitively expensive or unreliable if done manually by nursing staff with infusion pumps. For instance, they can administer injections at a rate of 0.1 mL per hour (too slow for a drip), give injections every minute, give injections with repeated boluses at the patient's request, up to a maximum number per hour (for instance, in patient-controlled analgesia), or give fluids whose volumes vary throughout the day.

Infusion pumps are extensively utilized in numerous clinical settings, such as hospitals, home healthcare, and nursing homes. These units administer medication to patients requiring emergency care, oncology treatment, and pain management after surgery.

Infusion Pumps Market Size

Download a Free Sample To learn more about this report.

Products Insights

The market is segmented into insulin infusion pumps, large volume infusion pumps, syringe infusion pumps, enteral feeding pumps, and others. The insulin infusion pump segment owns the highest market share and is estimated to exhibit a CAGR of 8.23% during the forecast period. Insulin infusion pumps are used for continuous insulin delivery to a diabetic patient for a whole day. Insulin infusion pumps are wearable devices that a person can easily carry. These devices are probably used for type 1 diabetes care and reduce the risk of multiple insulin dosages by providing continuous insulin delivery. Wearable insulin infusion pumps also maintain the sugar levels in the human body. Such factors are expected to generate a higher demand for insulin infusion pumps. As per the American Diabetes Association, a 30%–40% surge in the type 1 diabetes patient population in recent years has propelled the demand for insulin. Increasing demand for insulin and rapidly increasing acceptance of insulin infusion pumps by healthcare professionals to treat diabetic patients have positively influenced the use of insulin infusion pumps.

Infusion Pumps Market Size By Segments

Request Customizationto receive a tailored report.

Technology Insights

The market is bifurcated into traditional infusion pumps and specialty infusion pumps. The traditional infusion pumps segment dominates the global market and is expected to exhibit a CAGR of 9.17% over the forecast period. Traditional infusion pumps are used for long-term home care and mobile care settings. These infusion pumps are used for drug administration procedures in mobile, ambulatory, and stationary environments. The increasing number of hospitals, ambulatory service centers, outpatient care centers, and infusion centers drive the demand for traditional infusion pumps. In addition, traditional infusion pumps can be classified into syringe and large-volume infusion pumps. These infusion pumps are mostly used to administer antibiotics, chemotherapy medications, pain medications, hydrating fluids, and other drugs.

Usage Insights

The market is divided into stationary infusion pumps and ambulatory infusion pumps. The stationary infusion pump segment accounts for a large market share and is expected to exhibit a CAGR of 7.19% throughout the forecast period. Stationary infusion pumps are large medical devices typically used in clinical and home medical settings. They are commonly used in hospitals, clinics, and home care settings. The high infrastructure growth in the healthcare industry and acceptance of technology-based medical devices are expected to drive the adoption of stationary infusion pumps as medication infusion systems. Large-volume infusion systems deliver saline solutions, nutritional medicines, and antibiotics. In addition, stationary infusion pumps are available for rent or are sometimes refurbished. The rising demand for rental large volume infusion pumps from hospitals, nursing homes, and outpatient care centers is fuelling the demand for stationary infusion pumps.

Application Insights

The market is divided into diabetes, oncology, gastroenterology, pediatric and neonatology, pain management, and others. The diabetes segment is the most significant contributor to the market and is predicted to exhibit a CAGR of 8.23% over the forecast period. Diabetes is a common chronic condition worldwide, which affected around 463 million population in 2020. Diabetes creates a major burden in healthcare services. The surging prevalence of diabetes and the growing demand for insulin infusions are fuelling the adoption rate of insulin infusion pumps. In addition, factors such as the expanding aging population, increasing life expectancy, and the rising diabetic population are major drivers for implementing infusion pumps in diabetes care. Technological advances in insulin infusion pumps will also drive market growth during the forecast period.

End-Users Insights

The market is divided into hospitals, home healthcare, nursing homes, and others. The hospital segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 7.35% over the forecast period. In hospitals, infusion pumps are a key tool for patient care in drug delivery. As per the American Society of Health-System Pharmacists (ASHP), the acceptance rate of smart infusion pumps increased from 44% to 73% between 2007 and 2014. Similarly, in 2019, the increasing acceptance of smart infusion pumps in small and larger hospitals witnessed a rapid surge. Infusion pumps are crucial to the safe administration of drugs in healthcare settings. Medication errors are reduced by infusion pumps, which can have other benefits. Infusion pumps are also used in clinical settings because they guarantee correct medicine delivery through programmed constant-rate drug delivery and 100% absorption bioavailability.

Infusion Pumps Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America infusion pumps market share is the most significant global market shareholder and is anticipated to exhibit a CAGR of 7.82% during the forecast period. North America is a well-developed region for healthcare services and technology implementation in the healthcare system. Factors such as increasing technological advances and the rising adoption rate of medical devices for drug delivery have enabled the higher growth of the North American market. In addition, the surging prevalence of chronic illnesses, like diabetes and cancer, is boosting the demand for infusion pumps in North America. As per a report by the IDF Diabetes Atlas, the number of diabetic individuals was around 48 million in 2019, which will witness a 33% growth to reach 63 million by 2045. Most US hospitals between 80% and 90% use cutting-edge, creative infusion pumps. A total of 0.5 million insulin infusion pump users are available in the US, while 10% of the diabetic population in Canada uses insulin infusion pumps. Such factors drive regional market growth.

North America Infusion Pumps Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe infusion pumps market growth is estimated to exhibit a CAGR of 8.75% over the forecast period. European countries have some of the best healthcare services due to increasing investment by several governments and rapidly growing health awareness among citizens. The expanding geriatric population and the increasing frequency of cancer, diabetes, and other chronic illnesses drive the regional market. Similarly, the rising demand for diagnostic services and increasing healthcare expenditure fuel the acceptance of infusion pumps in Europe. The region's increasing prevalence of gastroenterology diseases and colorectal cancer is accelerating the demand for infusion pumps. In addition, technological advances in the regional market are also generating new opportunities for market growth. The shift from hospital-based to home-based healthcare services has also created a lucrative growth opportunity for suppliers of ambulatory infusion devices.

Asia-Pacific Infusion Pumps Market Trends

Asia-Pacific has the highest population density and the largest proportion of elderly people. The region's flourishing prevalence of chronic diseases is driving the demand for infusion pumps. The continuously increasing burden of diabetes and other chronic diseases in Asia-Pacific has created a new opportunity for home healthcare infusion services. Rental and refurbished infusion pumps are commonly available in the Asia-Pacific region, which is expected to drive the adoption rate of infusion pumps in hospitals and outpatient care centers. Likewise, the increasing adoption of smart infusion pumps and the rising number of new product launches of technologically advanced infusion pumps are driving market growth. The rising acceptance of smart infusion pumps in hospitals and the growing demand for ambulatory infusion pumps are triggering the demand for infusion pumps.

Latin America is a developing region with a positive growth rate for healthcare services and solutions. Factors such as the expanding aging population and the soaring prevalence of chronic diseases drive the demand for the infusion pumps market in Latin America. Similarly, new product launches, technological advances, and the rise in demand for outpatient services and connected devices will drive the adoption of infusion pumps in the region. In 2020, the aging population accounted for nearly 8% of the total population. The population aged 65 and over will grow at a rate of 17.6% by 2050 and 30% by the end of the century. The increasing geriatric population is also augmenting the demand for healthcare services. Likewise, transitioning from hospitalization to home-based care and outpatient infusion services will drive market growth.

The Middle East and Africa is a developing region in the world. The increase in healthcare investment through FDI and initiatives to improve healthcare services have created tremendous opportunities for vendors of healthcare services. The rapidly expanding aging population and increasing burden of chronic diseases, such as diabetes, drive the regional market. Furthermore, the rising frequency of surgical procedures is accelerating the demand for infusion pumps in the region. In 2018, nearly 70% of premature deaths were attributed to chronic diseases. The increasing burden of chronic diseases and pain management has accelerated market growth.

List of Key and Emerging Players in Infusion Pumps Market

BD (Becton Dickinson)
Baxter International
B Braun Melsungen
ICU Medical
Medtronic
Micrel Medical Devices
Fresenius Kabi
Moog
Smiths Medical
Arcomed AG

Key Industry Developments

June 2026
ICU Medical launched the Plum Solo single-channel infusion pump in the United States following FDA clearance, expanding its connected infusion therapy portfolio with advanced interoperability, wireless connectivity, and streamlined medication delivery for acute care settings.
April 2026
Fresenius Kabi expanded its U.S. infusion portfolio by introducing new enhancements to the Ivenix Infusion System, strengthening smart infusion capabilities, cybersecurity, and hospital workflow integration.
January 2026
Medtronic received U.S. FDA approval for a manufacturing enhancement to its SynchroMed Infusion System, supporting continued production expansion and supply of implantable programmable infusion pumps.
September 2025
ICU Medical introduced new software and interoperability enhancements for the Plum Duo Infusion Pump, expanding integration with hospital electronic medical record systems and reinforcing its connected infusion management platform.

Report Scope

Segmentation

By Products 5
  • Insulin Infusion Pump
  • Large Volume Infusion Pump
  • Syringe Infusion Pump
  • Enteral Feeding Pump
  • Others
By Technology 2
  • Traditional Infusion Pumps
  • Specialty Infusion Pump
By Usage 2
  • Stationary Infusion Pump
  • Ambulatory Infusion Pump
By Applications 6
  • Diabetes
  • Oncology
  • Gastroenterology
  • Pediatric and Neonatology
  • Pain Management
  • Others
By End-Users 4
  • Hospital
  • Home Healthcare
  • Nursing Home
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage BD (Becton Dickinson) · Baxter International · B Braun Melsungen · ICU Medical · Medtronic
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The infusion pumps market size is valued at USD 18.07 Billion in 2026 and is projected to reach USD 34.70 Billion by 2034, at a CAGR of 8.5% during the forecast period 2026-2034.

North America dominated the market with a share of 39% in 2025.

The leading players in this market are BD, Baxter International, B Braun Melsungen, ICU Medical, Medtronic.

The infusion pumps market is projected to grow at a CAGR of 8.5% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: